• Call(WhatsApp Us)

    +8615360806100
  • Email Us

    cherry@laeyo.com
  • 广州市花都区花山镇华辉路18号

    微观化妆品创意产业园E栋整栋

Changing Skincare Manufacturers for a Saudi Brand: What Happens to Approved Product Artwork?

Switching manufacturers mid-flight is rarely just a supplier swap. For a Saudi skincare brand, the formula may survive the move intact — but the approved artwork usually does not. Artwork is not a design…

Category: Skincare Sourcing Guides • Author: laeyo • Published: 2026-11-04 • Views: 49

Switching manufacturers mid-flight is rarely just a supplier swap. For a Saudi skincare brand, the formula may survive the move intact — but the approved artwork usually does not. Artwork is not a design file; it is a regulated document that ties a specific product to a specific manufacturing site, a specific formula version, a specific importer/notifier, and a specific notification record. This guide walks through what actually changes, which decisions must be made before you send a single file to print, and which evidence to collect so your relaunch does not stall at customs or at the label desk.

Why artwork is a legal document in this market, not a layout

In the Saudi framework — the SFDA cosmetics framework layered with GSO safety and claims standards — the label is one of the primary control points. It is read alongside the notification file, not in isolation. When the manufacturing site changes, several artwork fields stop being true at the same moment.

  • Facility identity. Manufacturer name, address, and facility references must match the site that actually made the batch.
  • Formula identity. The INCI declaration must match the current, signed formula — not the version your previous factory produced.
  • Responsible entity. The Saudi importer or notifier carries the legal responsibility for placing the product on the market, and their details appear in the file and often on the pack.
  • Notification linkage. The notification record references the product and the responsible entity. A silent site change can leave the record describing a product that no longer exists.

Practical rule: treat artwork as a controlled document with a version number, a change log, and a named approver. If you cannot state which artwork version was approved, for which site, and against which formula, you are not ready to print.

First decision: which of three change scenarios are you in?

Everything downstream — timeline, testing, artwork scope — depends on this classification. Get it wrong and you either over-test or under-document.

Scenario What it means Artwork impact Minimum extra work
A — Site transfer, same formula, same ingredient suppliers Lowest risk. Same recipe, same raw materials, different building. Manufacturer block, facility references, batch coding format, possibly country of origin. Site-level verification: GMP certificate, equipment/process comparison, stability and micro at the new site, label adhesion on the production pack.
B — Same formula, new ingredient suppliers Identical INCI names, different source. Activity level, salts, solvents, particle size, impurities, colour, odour, and preservative interactions can all shift. Usually no change to INCI text, but warnings, allergen declarations, and claims support may change. Supplier-change control: COA comparison, small trial, key stability, viscosity/pH/appearance, sensory evaluation, preservative and efficacy checks as needed, cost and supply review.
C — Reformulation or new claims Highest risk. New INCI list, new efficacy evidence, potentially a new product identity. Full artwork rebuild. New INCI, new claims, new substantiation, new notification data. Full development and safety file: stability, micro, compatibility, claim testing, updated fragrance documentation.

If you are unsure, assume Scenario B until the COA comparison proves otherwise. “Same INCI” is not evidence of sameness.

Element-by-element: what actually changes on the pack

Use this as a redline worksheet. Every row you tick must be backed by a document — not by a verbal confirmation.

Artwork element Changes on manufacturer switch? Evidence to request Owner
Manufacturer name and address Almost always Current facility license / GMP certificate naming the site Manufacturer
INCI declaration Only if formula or supplier grades change Signed formula + ingredient-to-INCI mapping + COAs Manufacturer
Importer / notifier block Only if the responsible entity changes Written confirmation of notifier identity and role Buyer / Importer
Notification reference (if printed) Yes, if the record is updated Updated notification record from the SFDA electronic system Importer / Notifier
Batch and expiry coding Often — new site, new coding hardware Printed-sample photo showing actual batch and expiry format Manufacturer
Warnings and allergen statements Possibly, if fragrance or preservative system changes IFRA certificate written against the actual product use category, plus allergen declaration Fragrance house / Manufacturer
Claims and directions for use Possibly — must remain supportable Claim substantiation file mapped claim-by-claim to test data Buyer / Manufacturer
Net content and units Only if fill weight or format changes Fill-weight control spec and check-weigher records Manufacturer
Barcode / GS1 data No, unless the GTIN changes with the brand owner GS1 registration confirmation and barcode verification report Buyer
Label substrate and adhesive Yes, in practice — new bottle supplier, new press Label adhesion and artwork compatibility report on production containers Packaging supplier / Manufacturer

Who owns what between buyer and factory

Most delays at this stage are not technical failures — they are ownership failures. Agree the split in writing before the artwork redline begins.

Workstream Owner Deliverable
Formula, specification, INCI mapping Manufacturer Signed formula and spec sheet
Safety and technical documents Manufacturer + fragrance house COA, SDS, IFRA certificate matched to real use category
Stability, microbiology, packaging compatibility Manufacturer / contracted lab Protocols plus signed reports by batch
Product notification, import permit, local barcodes Saudi importer / notifier Notification record and import approval
Final Arabic and English label approval Buyer / importer Signed label approval sheet
Advertising and claim compliance Buyer with regulatory review Approved claim list with substantiation

Claims guardrails that artwork changes usually break

  • Cosmetics cannot carry medicinal or therapeutic claims. Wording that implies treatment of a condition, or aromatherapy benefits such as aiding sleep or treating anxiety, can shift how the product is classified and create non-compliance risk.
  • Stay on the performance side of the line. “Fuller-looking,” “lightweight,” “helps reduce the appearance of” are defensible when you hold data. “Repairs,” “heals,” “treats” require a different regulatory pathway.
  • IFRA documents must match the real use. A rinse-off and a leave-on application of the same fragrance can carry different limits. Ask for the certificate written against your actual product category, and re-check it for amendments at each project review.
  • Registration is not approval. Facility registration and product listing are mandatory compliance steps, not an endorsement of quality or efficacy. Never let artwork, PDP copy, or marketplace bullets imply otherwise.

Sequencing that avoids reprinting

  1. Freeze the current approved artwork. Record the version, the approver, and the date. Everything else is compared against this baseline.
  2. Run a gap assessment between the old and new site: equipment, process, water system, filling line, coding hardware.
  3. Collect the new site’s document pack before any design work starts.
  4. Redline only what the evidence supports. No speculative edits.
  5. Translate and review in-market. Arabic review plus allergen and warning check.
  6. Pre-press proof and barcode verification. Signed PDF, not an email attachment labelled “final”.
  7. Pilot run, then first-article inspection — including label adhesion on the actual production container.
  8. Update the notification and secure the import permit before commercial production is released.
  9. Archive the released artwork with its supporting evidence pack.

Fast path vs. standard path

Fast path is only available in Scenario A, with an unchanged formula, unchanged fragrance, unchanged packaging supplier, and a notifier who confirms in writing that no file update is required. What can compress: design rounds, translation turnaround, and printing lead time. What cannot compress: stability and micro at the new site, and the pilot run.

Standard path applies to Scenario B and C, or to any case where the notifier has not yet confirmed the file status. Budget for supplier-change evaluation, a fresh stability window, and a full label review cycle.

Do-not-cut red lines

  • Do not print packs naming a facility that did not manufacture the batch.
  • Do not reuse an INCI block without matching it line-by-line against the signed formula and COAs.
  • Do not skip stability and microbiological testing at the new site because “the formula is the same.”
  • Do not skip label adhesion and compatibility testing on the production container.
  • Do not accept an IFRA document that does not name your product’s actual use category.
  • Do not let the notification record describe a product configuration you no longer sell.
  • Do not approve artwork before the pilot run has produced a physical, inspected sample.
  • Do not allow any claim to remain on pack that is not mapped to a test report or a documented safety assessment.

Common failure modes and how to prevent them

1. Old factory name ships on the carton

  • Symptom: Bulk cartons arrive printed with the previous manufacturer’s details.
  • Root cause: No artwork version control; the printer reused a previous PDF.
  • Prevention: Change-control form per SKU, pre-press signoff, and first-article inspection before the full run.
  • Evidence to request: Approved artwork PDF with version number, printer’s proof, and first-article photographs.

2. Labels lift, curl, or wrinkle on the new bottle (packaging compatibility)

  • Symptom: Edge lifting after 48–72 hours, bubbling on the shoulder, or ink scuffing in transit.
  • Root cause: Different bottle resin or surface treatment, a new label converter, or an adhesive never validated against the production container.
  • Prevention: Adhesion testing on production containers, storage at elevated temperature and humidity, and drop/transit simulation.
  • Evidence to request: Label adhesion and artwork compatibility report, plus stability photographs at defined intervals.

3. Pump output or leak performance drops

  • Symptom: Dose per actuation drifts, or product seeps at the crimp.
  • Root cause: Small viscosity or pH shift from new raw material grades, or a pump lot change.
  • Prevention: Lock viscosity and pH specifications, run pump output and leak tests on the pilot batch, and approve the pump lot.
  • Evidence to request: Viscosity/pH specification with measured values, pump dose and leak test data, and a sealing integrity report.

4. INCI text on pack does not match the formula (documentation failure)

  • Symptom: A regulatory reviewer or a customer spots a missing or misordered ingredient.
  • Root cause: Artwork was edited from an older file; the new factory’s ingredient declarations were never reconciled.
  • Prevention: One signed formula version feeding one INCI mapping, reconciled before redlines are issued.
  • Evidence to request: Signed formula, ingredient-to-INCI mapping, and COAs from the actual production lots.

5. Shipment held because the notification does not match

  • Symptom: Customs or the market authority queries the product details against the file.
  • Root cause: The notifier was never told the manufacturing site changed.
  • Prevention: Written confirmation from the notifier on file status before production release.
  • Evidence to request: Updated notification record plus the notifier’s written statement of what changed and when.

6. Missing stability or micro data from the new site

  • Symptom: The buyer cannot complete the technical file; retail or distributor onboarding stalls.
  • Root cause: The old site’s reports were assumed to transfer. They do not.
  • Prevention: Commission site-specific stability and preservative efficacy work as part of the transfer plan.
  • Evidence to request: Study protocol, test conditions, timepoints, and a signed report referenced to the production batch.

7. Fragrance supplier change invalidates warnings and allergen text

  • Symptom: Allergen declarations on pack no longer reflect the fragrance actually used.
  • Root cause: The fragrance was sourced from a different house without a formal change assessment.
  • Prevention: Treat a fragrance supplier change as a high-risk change: assess exposure, re-review ingredient safety, decide on re-testing, and update safety documentation and warnings accordingly.
  • Evidence to request: Updated IFRA certificate for the correct category, full allergen declaration, revised safety assessment, and a documented decision on challenge testing.

8. Claims drift into therapeutic territory during the rewrite

  • Symptom: Copy that implies treatment of a skin condition appears on the new pack or listing.
  • Root cause: A copywriter or marketplace seller rewrote claims without regulatory review.
  • Prevention: Maintain one approved claim list; any new wording requires signoff and a mapped evidence source.
  • Evidence to request: Claim substantiation matrix and a dated regulatory approval of the final wording.

Copy-paste checklist for your supplier email

Confirm the change scenario: site transfer, supplier change, or reformulation.
Share the current approved artwork PDF with its version number and approval date.
Provide the new site's GMP certificate and facility license with expiry date.
Provide the signed formula and an ingredient-to-INCI mapping for the current version.
Attach COAs for all raw materials from the intended production lots.
Confirm whether any raw material supplier or grade changed versus the previous site.
Provide the IFRA certificate written against our actual product use category.
Attach the full allergen declaration for the fragrance as used.
Confirm stability protocol, timepoints, and whether new-site data already exists.
Confirm microbiological and preservative efficacy testing status at the new site.
Test label adhesion on the production container and share photographs.
Test pump dose, leak performance, and sealing integrity on the pilot batch.
Provide the viscosity and pH specification with measured pilot values.
List every artwork field that must change, with the document that justifies it.
Review all claims against the approved claim list and flag anything unsupported.
Confirm the batch and expiry coding format with a printed sample image.
Verify barcode and GTIN data with a barcode verification report.
Send a pre-press proof for written approval before printing.
Run the pilot and send first-article samples plus inspection photographs.
Confirm in writing who is the Saudi notifier and whether the file needs updating.
List the documents the notifier requires from the manufacturing site.
Approve final Arabic and English label text before mass production.
Hold commercial release until notification and import documentation are confirmed.
Archive the released artwork with its full evidence pack.

FAQ

Can we keep the same artwork if the formula is unchanged?

Rarely in full. Manufacturer name and address, facility references, and batch coding usually change. INCI text stays only if the formula and all raw material grades are genuinely identical — which must be proven by a COA comparison, not assumed from matching INCI names.

Who updates the product notification — the brand or the factory?

The Saudi importer or notifier is the responsible entity and owns the notification, import permit, local barcode data, and final Arabic/English label approval. The manufacturer supplies the underlying technical documents: formula, COA/SDS, GMP evidence, labels, samples, and stability or sealing data. Agree this split in writing at kickoff.

Do we need new stability and microbiological testing at the new site?

Yes, in most cases. Stability and preservative efficacy results are site- and process-specific. Even with an identical formula, equipment, water systems, filling conditions, and hold times differ and can change the outcome.

How long does the whole switch take?

It depends almost entirely on the scenario and on how quickly the notifier responds. A clean site transfer with existing documentation and a confirmed no-update file can move in weeks. A supplier change or reformulation adds trial work, a stability window, and a full label review cycle. Plan artwork approval after the pilot, never before.

Can we print artwork while testing is still running?

Print only fields that are already proven. Anything dependent on pending stability, fragrance documentation, or notification status should be held. Reprinting cartons costs far more than a two-week wait.

Next step

Send us the current approved artwork, the target market, your SKU list and formats, your positioning, your packaging direction, and your launch window. We will map the change scenario, list which artwork fields need new evidence, and return a document request list you can forward to your notifier the same day.

Request a Quote

Informational only, not legal advice. Regulatory requirements and notification procedures should be confirmed with your Saudi notifier and qualified regulatory counsel.

Hi, I'm your LAEYO representative, hope you like this blog post.

With more than 20 years of experience in OEM/ODM/Private Label Cosmetics, I'd love to share valuable knowledge related to cosmetics & skincare products from a top-tier Chinese supplier's perspective.

  • Our team will answer your inquiries within 8 hours.
  • Your information will be kept strictly confidential.

Request received

Thanks — we’ve received your request. Our team will follow up shortly. we typically reply within 8 hours (often sooner).